Pediatric Pharmacology 1 Lecture 10 PDF
Document Details
Uploaded by ThriftyChaos
State University of New York College of Optometry
Tags
Summary
This lecture provides information on pediatric pharmacology, specifically focusing on different types of eye drops (anesthetics, mydriatics, and cycloplegics) used in children. It discusses their mechanisms, indications, and potential side effects. The lecture also highlights important considerations for specific patient populations, such as premature infants and those with Down syndrome.
Full Transcript
§ Decreases corneal sensitivity § Improves transport of other agents across cornea § Indications...
§ Decreases corneal sensitivity § Improves transport of other agents across cornea § Indications § Before administration of other drops** § Corneal foreign body or injury § Tonometry à for glaucoma suspect § 0.5%/1% proparacaine, 0.4% benoxinate § With or without Fluorescein dye -use anesthetics in children when we are about to instill other drops such as tropicamide bc we know it stings so putting an anesthetic helps with comfort 11 Tropicamide § Muscarinic antagonist: paralyzes the iris sphincter and ciliary muscle § Concentrations: 0.5%, 1.0% § 0.5% used in younger than 1 yo and lighter irides § Poor cyclop legia effect with 0.5%! (can use that in albinism) § Rarely can cause C S N disturbance § Onset: 15-30 minutes § Duration 4-6 hours 12 Phenylephrine HCl (Neo-synephrine) § No cycloplegic effect § 2.5% maximum dose: 2 gtts spaced 5 mins apart § Use with caution in children with cardiovascular disease, premature infants and children in the first 6 months of life à 2.5% concentration § D O NOT USE 10% ! § 1% used in Cyclomydril generally safe in all infants § Paremyd (0.25% tropicamide and 1.0% p-hydroxyamphetamine) § Combo spray/drops: 0.5%Tropic + 2.5% Phenyl + 0.5% Cyclo à don’t last very long -don’t use it that much unless pt is a high myope -premature infants have immature kidneys but in general infants have immature kidneys 13 Atropine § Muscarinic antagonist: paralyzes the iris sphincter and ciliary muscle § Approved for 3 months and older CYCLOPLEGICS § 0.5% in light irides; 1.0% in darkly pigmented irides § Ointment or gtts instilled qhs for 3 nights before exam § Onset: 3-6 hours § Duration: 1 week (blur), 2 weeks (pupil dilation) -1% is approved for 3 months an older infants 14 Atropine § FDA approved for: dilation, cycloplegia, penalization (amblyopia), uveitis § Off-label use: myopia management (low CYCLOPLEGICS concentrations) § Children with Down syndrome, spastic paralysis, brain damage and very light pigmentation may be hypersensitive to the cholinergic antagonists § Ocular side effects: photophobia, blurred near vision, dilated pupils -only FDA approved myopia management is Misight aka multifocal CL 15 Atropine § Peripheral Signs of Atropine Toxicity § M u c o u s m em branes: D ry eyes, mouth, throat § Skin: Flushed, dry, hot, rash on face/mask CYCLOPLEGICS § Cardiovascular: Tachycardia, HTN § Respiratory: Tachypnea § G I : D ecreased peristalsis, abdom inal distension in infants § Genitourinary: Bladder distention, urgency § Other: Fever, headache -want to educate the parent on side effects before prescribing 16 Atropine § Central Signs of Atropine Toxicity § N eurologic Dysfunction: M uscle tremors, weakness § C erebellar Dysfunction: Ataxia, dysarthria, muscle incoordination CYCLOPLEGICS § Confusional psychosis: Restlessness, irritability, violent and aggressive behavior, confusion, disorientation, visual and tactile hallucinations § Term inal Phenom ena: convulsions, stupor, com a, death § Antidote: Physostigmine Salicylate -want to educate the parent on side effects before prescribing à put an effort to emphasize how dangerous the medication can be -does cross the BBB 17 Cyclopentolate § Muscarinic antagonist § Concentrations: (2 gtts separated by 5 minutes) § Under 1 year: 0.5% § O ve r 1 year: 1.0% CYCLOPLEGICS § Premature or LBW:1 gtt C yclom yd ril (0.2% C/1% PE) § Down syndrome § Onset: 15-30 minutes § Maximum Cycloplegia: 40 minutes à need to wait the full 40 mins to do cycloplegic testing § Duration: 6-8 hours, up to 24 hours à parents usually complain that child still has blurred vision post drops and ensure parent it is normal § Do N O T use 2% due to risk of side effects -dr. Vaughn uses 1% phenyl in down syndrome children bc they have lower accommodation to being with you don’t need a high dosage 18 Cyclopentolate § Used vs. atropine for shorter duration of action § Used vs. tropicamide for stronger cycloplegic effect CYCLOPLEGICS § Ocular side effects: photophobia, blurred near vision, pupil dilation § Systemic adverse effects: similar to atropine, but occur less frequently § Nervous system alterations have been reported: hallucinations, disorientation, memory loss, confusion 19 Tropicamide 1% § Less potent cycloplegic: very safe, less adverse effects compared to atropine § Onset: 15-30 minutes CYCLOPLEGICS § § Duration 4-6 hours Myopes: 2 gtts 1% T 5 mins apart is as effective in cycloplegia as 1% C (cyclopentolate should still be used in hyperopes!) § Scopolamine and Homatropine: rarely used 20 § Healthy 7-month-old infant: 0.5% cyclopentalate (2 gtt 5 mins apart) § 3-year-old Hispanic child: 1% cyclopentalate (2gtt 5 mins apart) § 3-year-old child with esotropia that did not dilate with 2 gtts 1% cyclo: 1% atropine at bedtime, 3 nights once a night before the exam) § 2-year-old toddler with Down syndrome: 0.5% cyclopentalate (punctal occlude according to the literature) or 1% cyclopentalate can be used 21 § First time patients: tropicamide and cyclopentolate § Amblyogenic dry retinoscopy: cyclopentolate THEN tropicamide § Degenerative myope (s amblyopia): tropicamide and phenylephrine “WHAT DROPS § Low to moderate myopes (s amblyopia): 2 gtts 1% T 5 mins apart DOYOU WANT TO § Low hyperope with 20/20 vision and no systemic issues: tropicamide USE?” § Persistent amblyopia: cyclopentolate THEN tropicamide § Low refractive error with normal DFE last year: no drops! Dilate every 2 years § Pick the most important drop first! 22